Full-Time

District Leader

Multiple Teams

Deadline 10/26/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$155k - $240k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

Ohio, USA

In Person

MD, Bachelor of Science (BS)

Category
Retail (1)
Required Skills
Inventory Management
Word/Pages/Docs
Customer Service
Excel/Numbers/Sheets
Microsoft Outlook

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • A bachelor's degree is required.
  • A Bachelor of Science degree in Pharmacy or Doctorate of Pharmacy is required.
  • An active Pharmacist license is required for all states in the district.
  • Internal candidates must be accepted into the EL program.
  • At least 5 years of experience as a practicing Pharmacist, ideally in a retail setting, is required.
  • At least 3 years of experience leading others is required.
  • Demonstrated ability to set and meet performance goals is required.
  • Strong interpersonal skills demonstrated by successful collaboration to achieve shared goals are required.
  • Strong time management skills, evidenced by accountability for multiple deliverables on staggered deadlines, are required.
  • Strong personal integrity and judgment, including a track record of managing highly sensitive or highly visible business matters, are required.
  • Strong communication skills in both formal and informal writing and speech are required.
  • A demonstrated growth mindset and willingness to learn and accept feedback are required.
  • Proficiency in Microsoft Teams, Word, Excel, PowerPoint, and Outlook is required.
Responsibilities
  • Cultivate and maintain a healthy Pharmacist talent pipeline, including overseeing intern development, recruiting new graduates, and supporting career progression for Float and Staff Pharmacists to maintain a strong Pharmacy Manager bench.
  • Set the district talent agenda for hourly colleagues, including staffing pipelines, district-level succession planning, and partnering with front store field leadership on cross-trained colleagues and total-store staffing.
  • Set and communicate district priorities based on corporate and regional direction, and ensure Pharmacy Managers understand and implement new initiatives.
  • Conduct regular formal and informal check-ins with all Pharmacy Managers to track progress against business and developmental goals.
  • Improve district-level pharmacy performance measures, including workflow, service, inventory management, and patient care, by coaching Pharmacy Managers to identify and address root-cause barriers.
  • Oversee patient safety and provide regulatory oversight, including reporting and investigating patient safety and drug loss incidents.
  • Grow the business through active pursuit and engagement with acquisitions, file buys, new stores, and remodels.
  • Cultivate the market's Pharmacist talent pipeline, including ultimate oversight and development of interns, Float Pharmacists, Staff Pharmacists, and Pharmacy Managers.
  • Manage district succession plans and promote district-level staffing of pharmacies.
  • Oversee the consistent delivery and completion of all colleague training programs.
  • Oversee appropriate staffing, scheduling, and timely and correct payment of all market Pharmacists.
  • Create a culture of recognition, empowerment, development, and inclusion that attracts and retains pharmacy talent at all levels.
  • Identify, mentor, and develop future district leadership talent.
  • Deliver timely performance reviews and targeted coaching and counseling for individual Pharmacy Managers as needed.
  • Develop and execute business plans and strategies for business performance measures, including P&L, scripts-to-budget, inventory management, payroll management, and asset protection accountabilities.
  • Review business reports to derive insights about district pharmacy performance, use metrics to diagnose root causes, and create action plans.
  • Analyze the competitive landscape and business trends to proactively plan for risk and capitalize on opportunities.
  • Set, communicate, and execute market goals.
  • Engage pharmacy teams to deliver new and existing programs and services with excellence.
  • Champion differentiated customer service and personally resolve escalated customer service issues.
  • Triage and address emergent market issues, including theft, extreme weather, no-shows, and Board of Pharmacy visits.
  • Ensure pharmacies are ready for inventories, internal and external audits, and other activities requiring planning and preparation.
  • Ensure compliance with community responsibility activities.
  • Ensure compliance with company policies and relevant federal, state, and local laws pertaining to pharmacy and pharmacy personnel.
  • Provide market-specific input to local acquisition and real estate strategy, implement the local real estate strategy, and provide acquisition support.
  • Identify file-buy and acquisition leads, cultivate competitor relationships, and ensure retention of file-buy assets.
Desired Qualifications
  • A PharmD is preferred.
  • Internal candidates are preferred to have completed the EL program curriculum through the EL Summit.
  • At least 3 years of experience as a multi-unit manager is preferred.
  • At least 1 year of experience in CVS Retail store or field roles is preferred.
  • Eight to ten years of work experience is preferred.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS Caremark settled FTC probes July 14, 2026, reducing legal overhang.
  • CVS expanded Eli Lilly weight-loss access in early fourth quarter 2026.

What critics are saying

  • Louisiana's February 2026 $45 million settlement keeps PBM reform pressure on Caremark margins.
  • Aetna paid $117.7 million on March 11, 2026 for Medicare coding fraud allegations.
  • Federal and state antitrust actions threaten a Caremark-Aetna breakup by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across 87 million PBM members.
  • CVS combines retail, insurance, and PBM data under one operating system.
  • CVS launched Google Cloud partnerships and AI tools across claims, service, and engagement.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 28th, 2026
CVS stock down 12% in a month despite 34% annual gain, faces 2027 headwinds

CVS Health stock has declined 12.3% over the past month, sitting about 15% below its 52-week high, though it remains up 34% over the trailing twelve months. The company's revenue reached approximately $415 billion, up 7.4% year-over-year. Management raised its full-year 2026 adjusted earnings per share guidance by $0.60 to a range of $7.90 to $8.10. For 2027, the company anticipates membership declines at Caremark and continued 340B programme pressure, offset by Aetna's recovery, which added over $2 billion in adjusted operating income in the first half of 2026. Management considers a 2027 adjusted EPS outlook of at least $8.44 reasonable. Historically, CVS has experienced varied recovery periods following market downturns, with some rebounds taking years rather than months.

Yahoo Finance
Aug 25th, 2026
CVS and Roche stocks could benefit from expanding GLP-1 drug market

CVS Health and Roche could benefit from the growing GLP-1 drug market, alongside current leaders Eli Lilly and Novo Nordisk. CVS Health has improved its financial performance, with second-quarter revenue rising 7.3% year-over-year to $106.1 billion and adjusted earnings per share increasing 42.5% to $2.58. The pharmacy chain offers all approved GLP-1 medicines in the US, including Eli Lilly's Zepbound and Foundayo, plus Novo Nordisk's Wegovy. CVS also provides low-cost online consultations at $29 to assess patient eligibility for GLP-1 drugs. Beyond GLP-1 initiatives, CVS is addressing previous business challenges and is positioned to capitalise on rising healthcare spending in the US over the next decade.

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.